Related Experiment Videos
Exchange transfusion for sickle cell intrahepatic cholestasis
Archives of Internal Medicine
|October 1, 1980
Summary
Sickle cell intrahepatic cholestasis (SCIH) is often fatal. However, partial blood-plasma exchange transfusion successfully treated SCIH, reversing complications and improving patient outcomes.
Area of Science:
- Hematology
- Hepatology
- Critical Care Medicine
Background:
- Sickle cell intrahepatic cholestasis (SCIH) is a severe complication of sickle cell disease.
- SCIH has a high mortality rate, typically due to liver failure or hemorrhagic diathesis.
Observation:
- Previous reports indicated a very low survival rate for patients with SCIH.
- This case report details a patient with SCIH who underwent a novel treatment approach.
Findings:
- Partial blood-plasma exchange transfusion was administered to a patient with SCIH.
- The treatment resulted in rapid clinical improvement within 48 hours, including regression of hepatic encephalopathy and bleeding diathesis.
- Serum bilirubin levels decreased significantly, from 146 mg/dL to 16 mg/dL within six days.
Implications:
- Partial blood-plasma exchange transfusion may represent a valuable therapeutic option for managing SCIH.
- This treatment approach could potentially improve survival rates in patients with this critical condition.
- Further research is warranted to confirm the efficacy and safety of this intervention in a larger cohort.